Neuroinflammation in Alzheimer's disease.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Lancet Neurology

• Publication date

  2015-04-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/S1474-4422(15)70016-5PMID 25792098PMCID PMC5909703
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• AN IN VITRO

  2016cited by this paper
• Transcriptome-Based Network Analysis Reveals a Spectrum Model of Human Macrophage Activation

  2014cited by this paper
• Innate immune activation in neurodegenerative disease

  2014cited by this paper
• Body Fluid Cytokine Levels in Mild Cognitive Impairment and Alzheimer’s Disease: a Comparative Overview

  2014cited by this paper
• Pre-activated blood platelets and a pro-thrombotic phenotype in APP23 mice modeling Alzheimer's disease.

  2014cited by this paper
• Suppression of Alzheimer-Associated Inflammation by Microglial Prostaglandin-E2 EP4 Receptor Signaling

  2014cited by this paper
• Ear2 Deletion Causes Early Memory and Learning Deficits in APP/PS1 Mice

  2014cited by this paper
• Truncated and modified amyloid-beta species

  2014cited by this paper
• Alzheimer's disease risk gene CD33 inhibits microglial uptake of amyloid beta.

  2013cited by this paper
• Caspase Inhibitors Protect Neurons by Enabling Selective Necroptosis of Inflamed Microglia*

  2013cited by this paper
• Inflammatory components in human Alzheimer's disease and after active amyloid-β42 immunization.

  2013cited by this paper
• Biological and methodical challenges of blood-based proteomics in the field of neurological research.

  2013cited by this paper
• TREM2 variants in Alzheimer's disease.

  2013cited by this paper
• Integrated systems approach identifies genetic nodes and networks in late-onset Alzheimer's disease.

  2013cited by this paper
• CD33 Alzheimer’s disease locus: Altered monocyte function and amyloid biology

  2013cited by this paper
• Multiple effects of physical activity on molecular and cognitive signs of brain aging: can exercise slow neurodegeneration and delay Alzheimer’s disease?

  2013cited by this paper
• P4–029: Glutamate dysregulation in tau P301L mice

  2013cited by this paper
• The Microglial Sensome Revealed by Direct RNA Sequencing

  2013cited by this paper
• Microglia promote learning-dependent synapse formation through brain-derived neurotrophic factor.

  2013cited by this paper
• Imaging microglial activation and glucose consumption in a mouse model of Alzheimer's disease.

  2013cited by this paper
• CD36 coordinates NLRP3 inflammasome activation by facilitating the intracellular nucleation from soluble to particulate ligands in sterile inflammation

  2013cited by this paper
• Traumatic Brain Injury Precipitates Cognitive Impairment and Extracellular Aβ Aggregation in Alzheimer's Disease Transgenic Mice

  2013cited by this paper
• Results of a follow‐up study to the randomized Alzheimer's Disease Anti‐inflammatory Prevention Trial (ADAPT)

  2013cited by this paper
• IL12/23 p40 Inhibition Ameliorates Alzheimer's Disease-Associated Neuropathology and Spatial Memory in SAMP8 Mice

  2013cited by this paper
• Comment on “ApoE-Directed Therapeutics Rapidly Clear β-Amyloid and Reverse Deficits in AD Mouse Models”

  2013cited by this paper
• Cyclooxygenase‐1 inhibition reduces amyloid pathology and improves memory deficits in a mouse model of Alzheimer's disease

  2013cited by this paper
• Microglia and macrophages of the central nervous system: the contribution of microglia priming and systemic inflammation to chronic neurodegeneration

  2013cited by this paper
• Microglia Actively Regulate the Number of Functional Synapses

  2013cited by this paper
• Obesity and susceptibility to severe outcomes following respiratory viral infection

  2013cited by this paper
• Microglial beclin 1 regulates retromer trafficking and phagocytosis and is impaired in Alzheimer's disease.

  2013cited by this paper
• Astrocytes: conductors of the Alzheimer disease neuroinflammatory symphony.

  2013cited by this paper
• Comment on “ApoE-Directed Therapeutics Rapidly Clear β-Amyloid and Reverse Deficits in AD Mouse Models”

  2013cited by this paper
• Sustained Interleukin-1β Overexpression Exacerbates Tau Pathology Despite Reduced Amyloid Burden in an Alzheimer's Mouse Model

  2013cited by this paper
• Heme binding induces dimerization and nitration of truncated β-amyloid peptide Aβ16 under oxidative stress.

  2013cited by this paper
• Microglial activation in Alzheimer's disease: an (R)-[¹¹C]PK11195 positron emission tomography study.

  2013cited by this paper
• Reactive glia show increased immunoproteasome activity in Alzheimer's disease.

  2013cited by this paper
• Environmental enrichment prevents astroglial pathological changes in the hippocampus of APP transgenic mice, model of Alzheimer's disease.

  2013cited by this paper
• Comment on “ApoE-Directed Therapeutics Rapidly Clear β-Amyloid and Reverse Deficits in AD Mouse Models”

  2013cited by this paper
• In vivo radioligand binding to translocator protein correlates with severity of Alzheimer's disease.

  2013cited by this paper
• Richness of human gut microbiome correlates with metabolic markers

  2013cited by this paper
• Functional Impairment of Microglia Coincides with Beta-Amyloid Deposition in Mice with Alzheimer-Like Pathology

  2013cited by this paper
• Comment on “ApoE-Directed Therapeutics Rapidly Clear β-Amyloid and Reverse Deficits in AD Mouse Models”

  2013cited by this paper
• Traumatic brain injury: A risk factor for Alzheimer's disease

  2012cited by this paper
• Anti-inflammation Therapy by Activation of Prostaglandin EP4 Receptor in Cardiovascular and Other Inflammatory Diseases

  2012cited by this paper
• Inhibition of Microglial Activation Protects Hippocampal Neurogenesis and Improves Cognitive Deficits in a Transgenic Mouse Model for Alzheimer’s Disease

  2012cited by this paper
• Ensemble sparse classification of Alzheimer's disease

  2012cited by this paper
• NLRP3 is activated in Alzheimer´s disease and contributes to pathology in APP/PS1 mice

  2012cited by this paper
• A Paravascular Pathway Facilitates CSF Flow Through the Brain Parenchyma and the Clearance of Interstitial Solutes, Including Amyloid β

  2012cited by this paper
• Inhibition of NADPH oxidase promotes alternative and anti‐inflammatory microglial activation during neuroinflammation

  2012cited by this paper
• Noninvasive molecular imaging of neuroinflammation

  2012cited by this paper
• Norepinephrine: A Neuromodulator That Boosts the Function of Multiple Cell Types to Optimize CNS Performance

  2012cited by this paper
• Increased binding of peripheral benzodiazepine receptor in mild cognitive impairment-dementia converters measured by positron emission tomography with [¹¹C]DAA1106.

  2012cited by this paper
• Inflammatory prostaglandin E2 signaling in a mouse model of Alzheimer disease

  2012cited by this paper
• Plasma multianalyte profiling in mild cognitive impairment and Alzheimer disease

  2012cited by this paper
• Targeting Astrocytes Ameliorates Neurologic Changes in a Mouse Model of Alzheimer's Disease

  2012cited by this paper
• The immunology of neurodegeneration.

  2012cited by this paper
• Hippocampal expression of murine IL-4 results in exacerbation of amyloid deposition

  2012cited by this paper
• ApoE-Directed Therapeutics Rapidly Clear β-Amyloid and Reverse Deficits in AD Mouse Models

  2012cited by this paper
• Amyloid-related imaging abnormalities (ARIA) in Alzheimer’sdisease patients treated with bapineuzumab: A retrospective analysis

  2012cited by this paper
• Rejuvenation of regeneration in the aging central nervous system.

  2012cited by this paper
• Astrocytic cytoskeletal atrophy in the medial prefrontal cortex of a triple transgenic mouse model of Alzheimer’s disease

  2012cited by this paper
• PPARγ/RXRα-Induced and CD36-Mediated Microglial Amyloid-β Phagocytosis Results in Cognitive Improvement in Amyloid Precursor Protein/Presenilin 1 Mice

  2012cited by this paper
• Multivariate Protein Signatures of Pre-Clinical Alzheimer's Disease in the Alzheimer's Disease Neuroimaging Initiative (ADNI) Plasma Proteome Dataset

  2012cited by this paper
• Molecular Mechanisms Responsible for the Selective and Low-Grade Induction of Proinflammatory Mediators in Murine Macrophages by Lipopolysaccharide

  2012cited by this paper
• Nerve growth factor and brain-derived neurotrophic factor concentrations in schizophrenia: a review.

  2012cited by this paper
• Genetic variants influencing human aging from late-onset Alzheimer's disease (LOAD) genome-wide association studies (GWAS).

  2012cited by this paper
• Proteolytic degradation of amyloid β-protein.

  2012cited by this paper
• This information is current as Macrophages by Lipopolysaccharide Proinflammatory Mediators in Murine Selective and Low-Grade Induction of Molecular Mechanisms Responsible for the

  2012cited by this paper
• Inhibition of IL-12/IL-23 signaling reduces Alzheimer's disease–like pathology and cognitive decline

  2012cited by this paper
• Plasma biomarkers associated with the apolipoprotein E genotype and Alzheimer disease.

  2012cited by this paper
• Extensive innate immune gene activation accompanies brain aging, increasing vulnerability to cognitive decline and neurodegeneration: a microarray study

  2012cited by this paper
• Pneumococcal infections and adult with risk factors.

  2012cited by this paper
• The noradrenaline precursor L-DOPS reduces pathology in a mouse model of Alzheimer's disease.

  2012cited by this paper
• Plasma Brain-Derived Neurotrophic Factor Levels Predict the Clinical Outcome of Depression Treatment in a Naturalistic Study

  2012cited by this paper
• Caspase signalling controls microglia activation and neurotoxicity

  2011cited by this paper
• Osteoarthritis accelerates and exacerbates Alzheimer's disease pathology in mice

  2011cited by this paper
• Physiology of microglia.

  2011cited by this paper
• Multiple cellular and molecular mechanisms Are involved in human Aβ clearance by transplanted adult astrocytes

  2011cited by this paper
• Docosahexaenoic Acid-Derived Neuroprotectin D1 Induces Neuronal Survival via Secretase- and PPARγ-Mediated Mechanisms in Alzheimer's Disease Models

  2011cited by this paper
• Alzheimer's disease.

  2011cited by this paper
• Critical Role of Astroglial Apolipoprotein E and Liver X Receptor-α Expression for Microglial Aβ Phagocytosis

  2011cited by this paper
• Inflammasome activation and IL-1β and IL-18 processing during infection.

  2011cited by this paper
• Hippocampal expression of murine TNFα results in attenuation of amyloid deposition in vivo

  2011cited by this paper
• In vivo changes in microglial activation and amyloid deposits in brain regions with hypometabolism in Alzheimer’s disease

  2011cited by this paper
• Complement in the brain.

  2011cited by this paper
• Extended results of the Alzheimer's disease anti‐inflammatory prevention trial

  2011cited by this paper
• Distinct and Non-Redundant Roles of Microglia and Myeloid Subsets in Mouse Models of Alzheimer's Disease

  2011cited by this paper
• Nitration of tyrosine 10 critically enhances amyloid β aggregation and plaque formation.

  2011cited by this paper
• Diverse inflammatory responses in transgenic mouse models of Alzheimer's disease and the effect of immunotherapy on these responses

  2011cited by this paper
• Early astrocytic atrophy in the entorhinal cortex of a triple transgenic animal model of Alzheimer's disease

  2011cited by this paper
• Age-dependent decrease in glutamine synthetase expression in the hippocampal astroglia of the triple transgenic Alzheimer's disease mouse model: mechanism for deficient glutamatergic transmission?

  2011cited by this paper
• Proinflammatory cytokines, sickness behavior, and Alzheimer disease

  2011cited by this paper
• Activin A skews macrophage polarization by promoting a proinflammatory phenotype and inhibiting the acquisition of anti-inflammatory macrophage markers.

  2011cited by this paper
• Role of astrocytes in neurovascular coupling.

  2011cited by this paper
• Neurovascular pathways to neurodegeneration in Alzheimer's disease and other disorders

  2011cited by this paper
• Docosahexaenoic acid signalolipidomics in nutrition: significance in aging, neuroinflammation, macular degeneration, Alzheimer's, and other neurodegenerative diseases.

  2011cited by this paper
• Brain-derived neurotrophic factor levels in schizophrenia: a systematic review with meta-analysis

  2011cited by this paper
• In vivo imaging of neuroinflammation in the rodent brain with [11C]SSR180575, a novel indoleacetamide radioligand of the translocator protein (18 kDa)

  2011cited by this paper
• Impact and Therapeutic Potential of PPARs in Alzheimer's Disease

  2011cited by this paper
• Rosiglitazone does not improve cognition or global function when used as adjunctive therapy to AChE inhibitors in mild-to-moderate Alzheimer's disease: two phase 3 studies.

  2011cited by this paper

• Microglial, astrocytic, oligodendrocyte, B-/T-cell and neutrophil dysregulation in neuroinflammation of Alzheimer's disease and related dementias.

  2026cites this paper
• The Role of Protein Aggregation in Neurodegenerative Diseases: Molecular Mechanisms and Therapeutic Targets

  2026cites this paper
• Anti-Neuroinflammatory Effects of a Representative Low-Molecular-Weight Component Isolated from Codium fragile Through Inhibition of the NF-κB Pathway in Microglia and Macrophage Cells

  2026cites this paper
• Dietary and metabolic reprogramming alleviates neurodegeneration: a review of mechanisms and clinical implications

  2026cites this paper
• Immunometabolism Reframes Alzheimer’s Disease: From Systemic Dysmetabolism to Glial Rewiring

  2026cites this paper
• Identification of plasma inflammatory biomarkers for Alzheimer's disease reveals IFN-γ as a regulator of ACSL1-mediated microglia phenotype.

  2026cites this paper
• Oleanolic Acid and Alzheimer’s Disease: Mechanistic Hypothesis of Therapeutic Potential

  2026cites this paper
• Electrocorticographic, Astrocytic and Transcriptomic Signatures in the Triple Transgenic Mouse Model of Alzheimer's Disease submitted to Stearoyl-CoA Desaturase Inhibition.

  2026cites this paper
• In vitro investigation of miR-206-3p-loaded extracellular vesicles as modulators of Aβ-induced neurodegeneration.

  2026cites this paper
• Neuroinflammation as a Central Mechanism in Alzheimer’s Disease: Therapeutic Insights from Schiff Base Derivatives

  2026cites this paper
• β-amyloid and β-amyloid precursor protein synthesis and processing: effects of exercise and exercise-related injury.

  2026cites this paper
• The Role of Microglia in Central Nervous System Injury Caused by Pathogen Infections.

  2026cites this paper
• Exploring the phyto-neuro interface: Ursolic acid's neuroprotective potential through in-silico evaluation

  2026cites this paper
• The Role of Unmethylated 5′-C-Phosphate-G-3′ (CpG) Motifs in Mitochondrial and Bacterial DNA in the Pathogenesis of Alzheimer’s Disease

  2026cites this paper
• Neuroprotection beyond neurons: integrated biomarker-based and astroglia- or microglia-targeted approaches to combat neurodegenerative diseases

  2026cites this paper
• Genomic and ancestral variations linked to the development of post-acute sequelae of SARS-CoV-2 infection in Indian populations

  2026cites this paper
• A multi-target therapeutic framework for Alzheimer's disease: an integrative mechanistic review.

  2026cites this paper
• Research trends and frontiers of astrocytes in cognitive impairment: a bibliometric analysis from 2015 to 2024

  2026cites this paper
• Emerging Alzheimer's therapies: clinical efficacy versus economic feasibility.

  2026cites this paper
• Exploring Proteomic Differences in PBMCs for Sex-Specific Insights into Alzheimer's Disease

  2026cites this paper
• CRISPR–Cas technologies in neurodegenerative disorders: mechanistic insights, therapeutic potential, and translational challenges

  2026cites this paper
• Cognitive Decline and Neurodegenerative Markers in Psoriasis: The Role of APOE4 and Beta-Amyloid

  2026cites this paper
• Targeting Amyloid Beta Aggregation and Neuroinflammation in Alzheimer’s Disease: Advances and Future Directions

  2026influential citation
• Quantitative susceptibility mapping of the brain is associated with inflammatory changes in Alzheimer's disease related areas.

  2026cites this paper
• Elevated Na+/K+ Ratio in Alzheimer’s Disease: A Potential Biomarker for Braak Stage

  2026cites this paper
• Neuroinflammation in Alzheimer's Disease: The Role of Obesity, Gut Microbiota, and Therapeutic Potential of Omega-3 Fatty Acids and Neural Stem Cells.

  2026cites this paper
• α-Conotoxin LvID, an antagonist of α7 nicotinic acetylcholine receptor, mitigates Alzheimer-associated phenotypes by inhibiting Aβ deposition and reactive astrogliosis.

  2026cites this paper
• Carnosine protects human microglia against Aβ oligomers through a multimodal mechanism of action: inhibition of oxidative stress, rescue of cellular energy status, and enhancement of phagocytosis.

  2026cites this paper
• MOMHCA-SG: a multi-head cross-attention and similar graph convolutional network framework for Alzheimer's disease cell type classification.

  2026cites this paper
• Inflammatory stimulus enhances synaptic material uptake by adult APP microglia in a microfluidic neuron–microglia co-culture model

  2026cites this paper
• Association of moderate to vigorous physical activity with cognitive performance and risk of cognitive impairment: A cross-sectional study and Mendelian randomization analysis

  2026cites this paper
• Neuroinflammaging and Sex-Specific Mechanisms: Biomarker Discovery and Emerging Technological Approaches in Aging Brain Disorders

  2026cites this paper
• Procoagulant Extracellular Vesicles Increase Neuronal Tau expression, Metabolism and Processing Through Tissue Factor and Protease Activated Receptor 2

  2026cites this paper
• Plasma GFAP as a mediator and moderator of Aβ, tau, and neurodegeneration in Alzheimer’s disease

  2026cites this paper
• Comparative lipidomics of iPSC-derived microglia protocols reveal lipid droplet and immune differences mediated by media composition

  2026cites this paper
• Neuroendocrine signaling as a pathological seed for the female bias of Alzheimer's disease and the concept of estrobolome.

  2026cites this paper
• Investigating the impact of aspartame on Alzheimer’s disease through network toxicology and molecular docking

  2026cites this paper
• Neurotransmitter-based machine-learning model for distinguishing Alzheimer’s disease and mild cognitive impairment

  2026influential citation
• Mechanism of Exercise-Regulated Intestinal Flora for Alzheimer’s Disease Based on Gut–Brain Axis

  2026cites this paper
• Targeted Degradation of the NLRP3 Inflammasome via Microglial LC3-Associated Phagocytosis: A Novel Therapeutic Strategy for Alzheimer’s Disease Neuroinflammation

  2026cites this paper
• Experimental Models and Translational Strategies in Neuroprotective Drug Development with Emphasis on Alzheimer’s Disease

  2026cites this paper
• Neuroinflammation demonstrated by 11C‐ER176 PET with amyloid and tau pathology

  2026cites this paper
• Higher CSF sTREM2 is related to slower hippocampal atrophy and cognitive decline independently of pTau181 levels.

  2026cites this paper
• Spilling the T: T cells in tauopathy mechanisms, disease progression, and therapeutic horizons

  2026cites this paper
• Targeting the Nrf2/HO-1 aixs: a therapeutic strategy against regulated cell death in Alzheimer's disease.

  2026cites this paper
• Advances in design and application of molecularly imprinted polymers for selective brain protein recognition in neurology

  2026cites this paper
• Sex-specific effects of fecal microbiota transplantation on TBI-exacerbated Alzheimer’s disease pathology in mice

  2026cites this paper
• Potential Neuroprotective Role of GLP-2 in Alzheimer’s Disease: Clinical Observations, Mechanistic Insights, and Comparison with GLP-1

  2026cites this paper
• Dietary dihydroquercetin alleviates age-related cognitive impairment in association with modulation of apoptosis and pyroptosis pathways.

  2026cites this paper
• Association of Alzheimer's disease progression with YKL40 levels in peripheral blood and cerebrospinal fluid: a systematic review and meta-analysis.

  2026cites this paper
• Epigallocatechin Gallate and Punicalagin Combination Reduces Aβ Aggregation and Promotes Neurogenesis in Adult Zebrafish Brain

  2026cites this paper
• Multi-scale transcriptomic integration reveals cell-type immune networks and lncRNA remodeling in Alzheimer’s disease

  2026cites this paper
• CREB2 Functions as a Central Mediator of Oxidative Neuronal Death Triggered by Microglial Glutamate Release Under Neuroinflammatory Conditions.

  2026cites this paper
• Digital siblings unveil distinct molecular and clinical subtypes in Alzheimer's disease via omics-driven profiling.

  2026cites this paper
• Combining xQTL and genome-wide association studies from diverse populations improves druggable gene discovery.

  2026cites this paper
• ALDH2 activation protects against mutant TOMM40-mediated mitochondrial dysfunction and neurodegeneration in Alzheimer's disease.

  2026cites this paper
• Deletion of NLRP3 gene blocks traumatic brain injury induced abnormal immune response in 3xTg AD mice

  2026cites this paper
• Kynurenic acid derivatives in treatment for Alzheimer's disease.

  2026cites this paper
• Sphingolipids in Emotional Well‐Being

  2026cites this paper
• Targeting the Biology of Aging in Cerebrovascular Disease: Inflammation, Metabolism, Senescence, and Regeneration.

  2026cites this paper
• Rotating Magnetic Field Therapy Induces System-Level Neuroprotection in A53T α-Synuclein Transgenic Mice Through Coordinated Suppression of Cellular Stress Pathways

  2026cites this paper
• Protective mutations associated with APOE in Alzheimer's disease.

  2026cites this paper
• Nanomaterial strategies for mitigating protein misfolding and neuroinflammation in neurodegenerative diseases.

  2026cites this paper
• Advances in lipid-based nanosystems for mitochondrial metabolism modulation: strategies, mechanisms, and applications

  2026cites this paper
• A timeline of structural and functional consequences to ipRGCs in a mouse model of Alzheimer's disease.

  2026cites this paper
• Signaling roles for astrocytic lipid metabolism in brain function

  2026cites this paper
• Neuronal subtype governs amyloid structure, cellular response, and cognitive outcome in genetically targeted APP mouse models

  2026cites this paper
• Neuroprotection in the age of emerging infections: The untapped power of medicinal mushrooms.

  2026cites this paper
• Uncovering the role of integrated stress in Alzheimer’s disease through single-cell and transcriptomic analysis

  2026cites this paper
• Selective vulnerability of the aging cholinergic system to amyloid pathology revealed by induced APP overexpression

  2026cites this paper
• Treadmill Exercise Modulates TNF‐α and IL‐1β Expression in Rodent Models of CNS Inflammation: A Systematic Review

  2026cites this paper
• Genotype–phenotype interaction in Alzheimer's disease immune activation

  2026cites this paper
• CD8+ T cell aging is associated with macular neovascularization area change in neovascular age-related macular degeneration: a prospective cohort study

  2026cites this paper
• Through electrochemical sensors analyzing mechanism of neurons regulate astrocyte activity in Alzheimer's disease through the JAG2-NOTCH2 signaling pathway

  2026cites this paper
• Engineering neuroimmune regulation: biomaterial and nanotechnology platforms for neuropathology diagnosis and targeted immunomodulation

  2026cites this paper
• Multi-omics integration reveals distinct MCI subtypes with molecular and phenotypic heterogeneity in Alzheimer's disease progression

  2026cites this paper
• Microvascular Failure in the Aging Brain: Converging Pathways of Oxidative Stress, Inflammation, and Endothelial Decline

  2026influential citation
• Angiopoietin-2 aggravates Alzheimer's disease by promoting blood-brain barrier dysfunction and neuroinflammation.

  2026cites this paper
• Therapeutic potential of Oxalis corniculata in circumventing Alzheimer's disease through in vitro and in silico investigations.

  2026cites this paper
• Oxytocin Modulates Microglial IL-17-Linked Inflammatory Pathways Through the IL-6/COX-2

  2026cites this paper
• Targeting CHI3L1 in Alzheimer’s Disease: Optimization of G721-0282 and Functional Evaluation in Astrocyte Models

  2026cites this paper
• hUC-MSC-derived exosomes ameliorate Alzheimer's disease pathology through lncRNA-9969-mediated multi-target protection involving neuronal autophagy and microglial modulation

  2026cites this paper
• Comparative evaluation of large language models in retrieving known and predicting novel drug combinations.

  2026cites this paper
• Comparative Profiling of Mouse and Human Microglial Small Extracellular Vesicles Reveals Conserved Core Functions with Distinct miRNA Signatures

  2026cites this paper
• Synaptic Plasticity in Neurodegenerative Diseases: Impact of Exercise as Promising Therapeutic Tool

  2026cites this paper
• Engineering nanobodies for drug delivery systems in Alzheimer's disease.

  2026cites this paper
• Ginsenoside Rk1 alleviates lipopolysaccharide (LPS)-induced cognitive impairment by modulating synaptic plasticity

  2026cites this paper
• Deeper neuronal and glial proteomic insights using an optimized pipeline for proximity labeling proteomics

  2026cites this paper
• An integrated CSF-serum biomarker model for predicting clinical progression in Alzheimer’s disease

  2026cites this paper
• Probiotic and Dietary Supplements Intervention in Age-Related Neurodegenerative Disorders.

  2026cites this paper
• Biflavonoids can Potentially Inhibit Amyloid Beta Internalization to Mitigate Its Cytotoxic Events

  2026cites this paper
• The association of Alzheimer’s disease-related SNPs with mild cognitive impairment susceptibility in the Chinese population

  2026cites this paper
• PRISM‐xQTL: Pleiotropic Relationships Integrated with System‐level Multiomic QTL analysis for causal genes and molecular mediators in Alzheimer's disease

  2026cites this paper
• Adiponectin deficiency drives cerebrovascular dysfunction and synergizes with amyloid-β to exacerbate alzheimer’s pathology

  2026cites this paper
• Advances in Alzheimer's disease: mechanistic insights and therapeutic targets.

  2026cites this paper
• Repression of RIPK1 kinase by INPP5D inhibits expression of diverse proinflammatory mediators and late-onset Alzheimer's disease risk factors.

  2026cites this paper
• Glial and Neuronal Alzheimer's Disease-Related Alterations Reproduced in Human Induced Pluripotent Stem Cells With Presenilin-1 Mutation

  2026cites this paper
• Reduced serum AHR agonistic activity reflects amyloid dysregulation in AT1 subtypes of Alzheimer’s disease

  2026cites this paper
• Altered Microglia-Neuron Crosstalk and Regional Heterogeneity in Alzheimer’s Disease Revealed by Single-Nucleus RNA Sequencing

  2026cites this paper
• Sleep disturbances and Alzheimer's disease: a multiscale approach from exposome to neurobiology and precision medicine.

  2026cites this paper